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Drug-evoked synaptic plasticity in the mesolimbic
dopamine (DA) system reorganizes neural circuits
that may lead to addictive behavior. The first cocaine
exposure potentiates AMPAR excitatory postsyn-
aptic currents (EPSCs) onto DA neurons of the VTA
but reduces the amplitude of NMDAR-EPSCs. While
plasticity of AMPAR transmission is expressed
by insertion of calcium (Ca2+)-permeableGluA2-lack-
ing receptors, little is known about the expres-
sion mechanism for altered NMDAR transmission.
Combining ex vivo patch-clamp recordings, mouse
genetics, and subcellular Ca2+ imaging, we observe
that cocaine drives the insertion of NMDARs that
are quasi-Ca2+-impermeable and contain GluN3A
and GluN2B subunits. These GluN3A-containing
NMDARs appear necessary for the expression of
cocaine-evoked plasticity of AMPARs. We identify
an mGluR1-dependent mechanism to remove these
noncanonical NMDARs that requires Homer/Shank
interaction and protein synthesis. Our data provide
insight into the early cocaine-driven reorganization
of glutamatergic transmission onto DA neurons and
offer GluN3A-containing NMDARs as new targets in
drug addiction.
INTRODUCTION
Cocaine alters excitatory transmission onto synapses of dopa-
mine (DA) in the ventral tegmental area (VTA) within hours of
drug exposure. This early form of neuroadaptation persists days
after the drug has been cleared from the body (Lu¨scher and Mal-
enka, 2011). Much experimental evidence suggests that this
drug-evoked synaptic plasticity represents a trace that is permis-
sive for widespread circuit adaptations in the mesolimbic systemNeupon chronic drug exposure, eventually leading to addictive
behavior (Kauer andMalenka, 2007; Lu¨scher andMalenka, 2011).
Excitatory synapses in VTA DA neurons contain ionotropic
glutamate receptors of the AMPA (AMPARs) and NMDA
(NMDARs) type as well as group I metabotropic glutamate
receptors (mGluRs-I). AMPARs are the workhorse of synaptic
transmission; they are highly mobile and traffic at synapses
both constitutively and in an activity-dependent manner
(Lu¨scher and Malenka, 2011; Anggono and Huganir, 2012;
Sanz-Clemente et al., 2012). Recent work also suggests activ-
ity-dependent trafficking of NMDARs although a unified mecha-
nism for rules of trafficking has not been identified (Kwon and
Castillo, 2008; Rebola et al., 2008; Harnett et al., 2009).
mGluRs-I are localized perisynaptically but can modulate trans-
mission of AMPARs and NMDARs (Bellone et al., 2008; Lu¨scher
and Huber, 2010; Bellone et al., 2011; Matta et al., 2011).
Cocaine exposure profoundly changes AMPAR transmission
at excitatory synapses onto DA neurons in the VTA. The induc-
tion of cocaine-evoked synaptic plasticity of AMPAR transmis-
sion depends on the concomitant activation of D1Rs (Brown
et al., 2010) and NMDARs (Ungless et al., 2001; Engblom
et al., 2008). Its expression relies on an exchange of GluA2-
containing for GluA2-lacking, Ca2+-permeable AMPARs (CP-
AMPARs). Since CP-AMPARs have a higher single-channel
conductance, AMPA transmission at resting membrane poten-
tials is potentiated following a single cocaine injection.
One week after a single exposure to cocaine, the drug-evoked
plasticity of AMPAR transmission returns to baseline and the
mechanisms of this reversal phenomenon have been character-
ized (Bellone and Lu¨scher, 2006; Mameli et al., 2007). The recov-
ery of baseline transmission is driven by mGluR1, manifests as a
form of long-term depression (LTD), and involves an exchange of
CP-AMPARs for Ca2+-impermeable AMPARs (CI-AMPARs, Bel-
lone and Lu¨scher, 2006). This exchange requires fast and local
protein synthesis (Mameli et al., 2007), and reversal of cocaine-
evoked synaptic plasticity in the VTA has relevance within the
context of drug-seeking behavior (Mameli et al., 2009).
Interestingly, recent evidence suggests that 24 hr after
a single cocaine exposure in vivo, the amplitude of unitaryuron 80, 1025–1038, November 20, 2013 ª2013 Elsevier Inc. 1025
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GluN3A in Cocaine-Evoked PlasticityNMDAR-EPSC is reduced (Mameli et al., 2011). This indicates
that the increased AMPA/NMDA ratio observed ex vivo in many
studies (Ungless et al., 2001; Bellone and Lu¨scher, 2006) results
froma larger AMPAR-mediated component alongwith a reduced
amplitude of NMDAR-mediated component (Mameli et al., 2011).
While drug-evoked changes in AMPAR-mediated transmission
at excitatory synapses of VTA DA neurons have been extensively
studied, little is known about mechanisms that underlie the
expression and reversal of plasticity of NMDAR transmission.
NMDARs are heterotetrameric receptors typically containing
two GluN1 subunits together with a combination of two GluN2
(A-D) or one GluN2 and one GluN3 (A, B) subunit (Traynelis
et al., 2010). Thus, multiple NMDAR subtypes can exist and
accumulating evidence indicates that subunit composition
determines the receptor’s biophysical and pharmacological
properties, the quality of synaptic transmission, and the rules
for plasticity (Paoletti et al., 2013). Among the GluN2 subunit
family, GluN2A and GluN2B subunits are the most abundant in
the forebrain. They assemble as canonical heterodimeric or het-
erotrimeric NMDARs, which have a slow decay time kinetic
compared to AMPARs, have strong voltage-dependent Mg2+
block, and readily flux Ca2+ (Cull-Candy and Leszkiewicz,
2004; Traynelis et al., 2010; Paoletti et al., 2013). Less exten-
sively studied, GluN3A can form noncanonical NMDARs that
exhibit distinct properties. Consistent with themRNA expression
in the CNS, GluN3A expression peaks between postnatal days 7
and 10 in the cortex, midbrain, and hippocampus (Al-Hallaq
et al., 2002). In hippocampal slices from transgenic mice overex-
pressing GluN3A, NMDAR-EPSCs show reduced Mg2+ sensi-
tivity and the receptors have lower conductance (Roberts
et al., 2009). Moreover in neuronal cultures the shift in the
reversal potential at different Ca2+ concentrations suggest a
decreased Ca2+ permeability of neurons obtained from GluN3A
transgenic mice (Tong et al., 2008). Based on their functional
properties derived from investigation in heterologous expression
systems, it has been suggested that noncanonical GluN3-con-
taining NMDARs may affect synaptic plasticity and be involved
in various neurological diseases (Roberts et al., 2009; Pacher-
negg et al., 2012). The presence of GluN3A-containing NMDARs
has also been described in developmental synapses; however, it
remains unknown whether activity-dependent mechanisms can
drive their expression at juvenile and adult synapses.
Here we demonstrate that cocaine induces a switch of
NMDAR subunit composition at excitatory synapses on DA neu-
rons of the VTA, which reduces NMDAR function. This form of
cocaine-evoked synaptic plasticity is expressed by the insertion
of GluN3A-containing NMDARs that are quasi-Ca2+-imperme-
able and necessary for the expression of cocaine-evoked
plasticity of AMPARs at these synapses. Moreover, we find
that activation of mGluR1 potentiates NMDAR transmission after
cocaine exposure and restores basal NMDAR subunit composi-
tion via a protein-synthesis-dependent mechanism.
RESULTS
Ca2+ Permeability of NMDARs after Cocaine Exposure
At juvenile synapses, when synaptic transmission in the VTA has
already reached maturity (Bellone et al., 2011), exposure to1026 Neuron 80, 1025–1038, November 20, 2013 ª2013 Elsevier Inccocaine drives insertion of GluA2-lacking AMPARs and de-
creases NMDAR function at excitatory synapses onto DA neu-
rons (Bellone and Lu¨scher, 2006; Mameli et al., 2011). In order
to investigate whether the source of synaptic Ca2+ entry was
altered after a single cocaine injection (Figure 1A), we combined
two-photon laser microscopy and patch-clamp recordings to
image synaptic Ca2+ entry in response to activation of AMPARs
and NMDARs. All the Ca2+ imaging recordings were performed
in Mg2+-free solution. As previously described (Ungless et al.,
2001; Bellone and Lu¨scher, 2006), we observed an increase in
the AMPAR to NMDAR ratio after cocaine exposure (Figure S1,
available online). In parallel we detected synaptic Ca2+ transients
(Figures 1B–1E) at identified hotspots and measured mixed
AMPAR/NMDAR EPSCs (Figure 1F). In the saline condition
Ca2+ transients and NMDAR-EPSCs were abolished by the
selective NMDAR blocker DL-(-)-2-Amino-5-phosphonopenta-
noic acid (DL-APV, 50 mM, Figures 1D and 1F) while AMPAR-
EPSCs were still detectable (Figure 1F). When using the specific
CP-AMPAR blocker Philantotoxin 433 (PhTx, 2 mM), we found
little or no effect on both the Ca2+ transient (Figure 1D) and the
AMPAR-mediated EPSCs (data not shown; Bellone and Lu¨scher,
2006) in recordings from slices of saline-treated animals.
Conversely, in slices from cocaine-treatedmice, while DL-APV
abolished the NMDA-EPSC (Figure 1F), no significant effect on
the Ca2+ transient was detected (Figures 1E and 1F). In turn,
PhTx or the general AMPARs blocker NBQX abolished the
Ca2+ transient (Figures 1E and S2). Since all recordings were car-
ried out in a cocktail of blockers for voltage-gated calcium chan-
nels (Bloodgood et al., 2009; Bellone et al., 2011) and NBQX left
the NMDAR-EPSC untouched (Figure S2), CP-AMPARswere the
major source of synaptic Ca2+. Taken together, our data suggest
a scenario in which cocaine exposure triggers the insertion
of NMDARs that have very low Ca2+ permeability (quasi-Ca2+-
impermeable NMDARs).
Cocaine Changes the NMDAR Subunit Composition
Ca2+ permeability of NMDARs relies largely on the subunit
composition (Sobczyk et al., 2005). We next investigated
whether cocaine exposure affects the subunit composition of
NMDARs at excitatory synapses onto DA neurons. The selective
blockers of GluN2A- andGluN2B-containing NMDARs, Zn2+ and
ifenprodil, respectively (Paoletti, 2011), had differential effects in
slices from saline- and cocaine-treated animals. In slices from
cocaine-treated mice, NMDAR-EPSCs were strongly inhibited
by ifenprodil (3 mM, Figure 2A) while Zn2+ inhibition was modest
(Figure 2B). These results were inversed in slices of saline-in-
jected mice, where ifenprodil was inefficient but Zn2+ strongly in-
hibited NMDAR-EPSCs. Taken together, these data suggest
that the relative contribution of GluN2B subunits increased after
cocaine exposure. In agreement with this interpretation, the
decay time kinetic, measured as weighted tau (Tw), was slower
in slices obtained from cocaine-treated mice, again providing
evidence for an increased content of GluN2B subunits (Fig-
ure 2C, Bellone and Nicoll, 2007). Notably, we also observed
that ifenprodil treatment, while not affecting decay kinetics in
saline-treated mice, slowed the decay of NMDAR-EPSCs in
cocaine-injected animals (Figure S3A). This is consistent with
data showing that in a pure GluN1/GluN2B population, ifenprodil.
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Figure 1. Cocaine Switches Ca2+ Permeability from NMDAR to AMPAR Dependent
(A) Injection protocol.
(B) Image of a DA neuron at P18. Box represents the line scan position and ‘‘Stim’’ the position of the stimulating pipette.
(C) Green (Oregon Green BAPTA-1, 100 mM) and red (Alexa FluoRed 594 20 mM) fluorescence collected in a line scan mode during electrical stimulation at
synaptic hotspots. Scale bar represents 1 s.
(D) Bottom, bar graph indicating group data for the % of the remaining Ca2+ transient. Top, synaptic Ca2+ transients shown as DG/R fluorescence recorded
at 60 mV in Mg2+-free solution. (saline: 77.3% ± 13.8% of baseline in PhTx and 26.2% ± 2.0% of baseline in AP5, p < 0.001).
(E) Bottom, bar graph indicating group data for the % of the remaining Ca2+ transient. Top, synaptic Ca2+ transients shown as DG/R fluorescence recorded
at60mV inMg2+-free solution from cocaine-treatedmice. Scale bar represents 1%DG/R and 1 s. Cocaine: 81.9%± 9.0%of baseline in AP5 and 11.9%± 5.0%
of baseline in PhTx, p < 0.001.
(F) Ca2+ transient as a function of the normalized NMDAR-EPSCs recorded at 60 mV in Mg2+-free solution at baseline and in the presence of DL-APV. Insets
show dual AMPAR-NMDAR EPSCs where the amplitude of the NMDAR component was extracted at 20 ms after the stimulation (gray line). Scale bars represent
200 pA, 50 ms. Error bars represent SEM.
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GluN3A in Cocaine-Evoked Plasticitydecreases the glutamate dissociation rate (Gray et al., 2011).
Zn2+ affected the decay time kinetics both in saline- and in
cocaine-treated mice (Figure S3B). These data together strongly
favor an increase in the GluN2B to GluN2A ratio.
However, a change in the GluN2A/GluN2B ratio is not suffi-
cient to explain the lack of Ca2+ permeability observed following
cocaine exposure (Figures 1D and 1E). Indeed, both GluN2B and
GluN2A containing NMDARs are able to flux Ca2+ (Paoletti et al.,
2013). To further characterize the NMDAR subunit composition,
we plotted the current/voltage (I/V) relationship of NMDAR-
EPSCs in slices from cocaine- and saline-treated mice. Remark-
ably, NMDAR-EPSCs showed decreased outward rectification
in slices frommice injected with cocaine 24 hr earlier (Figure 2D).
The I/V relationship of NMDAR-EPSCs in saline- and cocaine-Netreated mice overlap if measured in a Mg2+-free solution, sug-
gesting an altered Mg2+ block after cocaine (Figure S3C). This
finding could be explained by the presence of GluN2C/D or
GluN3 subunits (Cull-Candy and Leszkiewicz, 2004). To examine
whether GluN2C/D subunits were involved in the cocaine-
evoked plasticity of NMDARs, we applied the recently described
selective potentiator of GluN2C/D, CIQ (20 mM, Mullasseril et al.,
2010). However, CIQ had no effect on the evoked NMDAR-
EPSC, indicating that the GluN2C/D subunit is not part of the
NMDAR subunit composition and not implicated in cocaine-
evoked plasticity (Figure S3D). To test for the presence of
GluN3 we took advantage of GluN3A knockout (KO) mice and
used heterozygous (Het) littermate mice as controls. These ani-
mals are fertile and follow a Mendelian distribution (Das et al.,uron 80, 1025–1038, November 20, 2013 ª2013 Elsevier Inc. 1027
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Figure 2. Cocaine Induces Changes in
NMDAR Subunit Composition
(A) Sample traces and amplitude versus time plot
of NMDAR-EPSCs recorded at +40 mV in the
presence of 3 mM ifenprodil. Saline: 77.3%± 2.6%,
n = 9; cocaine, 49.3% ± 1.3%, n = 7. p < 0.001.
(B) Sample traces and effects of 300 nM Zn2+ on
NMDAR-EPSCs recorded at +40 mV. Percentage
of inhibition in saline 56.9% ± 9.2%, n = 6; cocaine
37.8% ± 5.9%, n = 6. p < 0.05).
(C) Scaled sample traces and decay time for
NMDAR-EPSCs recorded at +40 mV (Tw in saline:
104.7 ± 16.2 ms, n = 7; cocaine: 182.1 ± 24.7 ms,
n = 7. p < 0.01).
(D) Sample traces aswell as I-V plots of normalized
and averaged NMDAR-EPSCs of VTA DA neurons
(60 mV in saline: 13.7% ± 2.2% of +40 mV, n =
8; cocaine:27.8% ± 4.5% of +40 mV, n = 17. p <
0.05) (80mV in Saline:6.9% ± 1.6% of +40 mV,
n = 7; cocaine: 26.5% ± 5.5% of +40 mV, n = 11.
p < 0.05).
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GluN3A in Cocaine-Evoked Plasticity1998). In GluN3A-KO mice, but not in heterozygous controls,
cocaine-evoked plasticity of NMDARs was absent, as demon-
strated by the normal I/V curve of the NMDAR-EPSCs (Figures
3A and 3B), the sensitivity to ifenprodil, and the decay time
kinetic (Figures S4A and S4B). These results suggest that the
expression of cocaine-evoked plasticity of NMDAR requires an
increase in both the GluN2B and GluN3A content.
GluN3A Gates Cocaine-Evoked Plasticity of AMPARs
Cocaine-evoked synaptic plasticity is induced by NMDAR acti-
vation and expressed by a change in both AMPAR and NMDAR
receptor subunit composition. To test whether the changes in
AMPAR- and NMDAR-mediated transmission are related, we
examined cocaine-evoked plasticity of AMPAR transmission
(by quantification of the rectification index, Bellone et al., 2011)
in mice lacking GluN3A. In heterozygous control mice AMPAR
EPSCs were rectifying 24 hr after single cocaine injection, con-1028 Neuron 80, 1025–1038, November 20, 2013 ª2013 Elsevier Inc.firming the presence of CP-AMPARs
as previously reported in wild-type mice
and rats (Bellone and Lu¨scher, 2006;
Argilli et al., 2008). We found no rectifica-
tion of AMPAR-EPSCs in GluN3A-KO
mice, indicating that CP-AMPARs were
not present at excitatory synapses onto
VTA DA neurons 24 hr after cocaine
exposure (Figures 3C and 3D). These
findings indicate that cocaine-evoked
plasticity of NMDARs, with the insertion
of nonconventional GluN3A-containing
NMDARs, represents a necessary step
for the expression of cocaine-evoked
AMPAR plasticity.
Global knockout mice often show
compensatory alterations and lack
regional specificity. To assess the spe-
cific role of GluN3A in cocaine-evokedsynaptic plasticity in VTA, we injected unilaterally an adeno-
associated viral vector expressing an anti-GluN3A short-hairpin
RNA (ShGluN3A) along with GFP into the VTA.We first confirmed
in vitro the selectivity of the ShRNA for GluN3A protein (Fig-
ure S4C) and we verified its expression in VTA DA cells 2 weeks
after the injection (Figures 3E and 3F). We examined cocaine-
evoked plasiticty of AMPARs and NMDARs in infected GFP-
expressing and noninfected contralateral cells and compared
results obtained from saline- and cocaine-treated mice. In
contralateral noninfected cells, cocaine drove the insertion of
GluN3A-containing NMDARs (Figures 3G, S4D, and S4E) and
GluA2-lacking AMPARs (Figure 3I). However, cocaine-evoked
plasticity of NMDAR (Figures 3H, S4D, and S4E) or AMPAR (Fig-
ure 3J) was not expressed in cells infected with ShGluN3A. The
NMDAR I/V curve and AMPAR RI in saline-treated mice was not
different from the values obtained in saline noninfected cells,
confirming that the ShGluN3A did not affect basal synaptic
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Figure 3. GluN3A Subunit Mediates the Expression of Cocaine-
Evoked Plasticity of AMPARs
(A) Sample traces as well as I-V plots of normalized and averaged NMDAR-
EPSCs (60 mV in saline: 16.3% ± 3.8% of +40 mV, n = 6; cocaine:
30.5% ± 6.2% of +40 mV, n = 9. p = 0.09) (80 mV in saline:10.4% ± 3.4%
of +40 mV, n = 6; cocaine: 33.1% ± 6.9% of +40 mV, n = 9. p < 0.05).
(B) Sample traces as well as I-V plots of NMDAR-EPSCs (60 mV in saline:
9.8% ± 1.5% of +40 mV, n = 7; cocaine:9.3% ± 1.2% of +40 mV, n = 9. p =
0.7) (80mV in saline:8.5%±2.6%of +40mV, n = 7; cocaine:5.6%±1.1%
of +40 mV, n = 9. p = 0.2). Scale bars represent 50 pA and 100 ms. Group
comparison statistic for (A) and (B): effect of drug (saline or cocaine) F(1,23) = 7.7,
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Netransmission. Taken together, our data indicate that cocaine-
evoked plasticity at excitatory synapses onto DA neurons is
induced by the insertion of GluN3A-containing NMDARs that
contribute to the expression of AMPAR plasticity.
Could knockdown of GluN3A in vivo be sufficient to disrupt
cocaine-related behaviors? To test this idea we bilaterally
injected the virus expressing ShGluN3A or only GFP in the
VTA. Three weeks later, allowing time for virus expression (Fig-
ure S5A), we exposed mice to a cocaine-conditioned place pref-
erence (CPP) task while simultaneously monitoring locomotor
activity. ShGluN3A and control animals showed comparable
locomotor sensitization to cocaine (10 mg/kg, i.p.) across condi-
tioning sessions and intact CPP (Figures S5B and S5C). These
data are in agreement with previous findings and a model
(reviewed in Lu¨scher and Malenka 2011) in which cocaine-
evoked plasticity at excitatory afferents onto VTA DA neurons
represents a metaplasticity that is permissive for subsequent
downstream changes coupled to long-term adaptive behaviors
such as drug seeking, in particular within the nucleus accum-
bens (Mameli et al., 2009). However, we cannot exclude the pos-
sibility that our manipulation lacks the efficiency of infection and
cell-type specificity necessary to reveal a role of GluN3A in acute
cocaine-related behaviors.p = 0.01; effect of GluN3A knockout (knockout or not), F(1,23) = 12.7, p < 0.01;
drug-knockout interaction, F(1,23) = 8.1, p = 0.01 (two-way ANOVA).
(C) Sample traces of AMPAR-EPSCs (70, 0, and +40 mV) and bar graph of
rectification index (saline: 0.92 ± 0.06, n = 6; cocaine: 1.44 ± 0.05, n = 9. p <
0.001). Scale bars represent 50 pA and 10 ms.
(D) Sample traces of AMPAR-EPSCs (70, 0, and +40 mV) and bar graph of
rectification index (saline: 0.93 ± 0.07, n = 8; cocaine: 0.98 ± 0.03, n = 8. p =
0.6). Scale bars represent 50 pA and 10 ms. Group comparison statistic for (C)
and (D): effect of drug, F(1,23) = 19.9, p < 0.001; effect of GluN3A (knockout or
not), F(1,23) = 10.3, p < 0.01; drug-knockout interaction, F(1,23) = 20.5, p < 0.001
(two-way ANOVA).
(E) Immunohistochemistry picture. Scale bar represents 100 mm. Green: GFP;
red: TH.
(F) Magnified picture (TH staining, red) by the shRNA-GFP virus (green); blue
shows the DAPI staining of the cell nuclei. Scale bar represents 20 mm.
(G) Sample traces as well as I-V plots of normalized and averaged NMDAR-
EPSCs (60mV in saline:15.4% ± 3.7% of +40 mV, n = 7; cocaine:9.9% ±
9.9% of +40 mV, n = 8. p = 0.07) (80 mV in saline: 8.5% ± 2.3% of +40 mV,
n = 7; cocaine: 38.4% ± 10.4% of +40 mV, n = 8. p < 0.05). Scale bars
represent 100 pA and 50 ms.
(H) Sample traces as well as I-V plots of normalized and averaged NMDAR-
EPSCs (60 mV in saline: 11.3% ± 1.7% of +40 mV, n = 6; cocaine:
12.4% ± 1.0% of +40 mV, n = 7. p = 0.2) (80 mV in saline: 6.9% ± 1.0%
of +40 mV, n = 6; cocaine: 6.2% ± 1.1% of +40 mV, n = 7. p = 0.6). Group
comparison statistic for (G) and (H): effect of drug (saline or cocaine), F(1,23) =
33.3, p < 0.001; effect of shRNA-GluN3A infection (knockdown or not), F(1,23) =
36.9, p < 0.001; drug-infection interaction, F(1,23) = 38.2 p < 0.001. Two-way
ANOVA. Scale bars represent 100 pA and 50 ms.
(I) Sample traces of AMPAR-EPSCs (70, 0, and +40 mV) and bar graph of
rectification index of VTA noninfected DA neurons recorded (saline: 1.09 ±
0.07, n = 6; cocaine: 1.58 ± 0.05, n = 9. p < 0.01). Scale bars represent 50 pA
and 5 ms.
(J) Sample traces of AMPAR-EPSCs (70, 0, and +40 mV) and bar graph of
rectification index (saline: 0.9 ± 0.09, n = 6; cocaine: 0.98 ± 0.07, n = 6. p = 0.6).
Group comparison statistic for (I) and (J): effect of drug (saline or cocaine),
F(1,23) = 17.2, p < 0.001; effect of shRNA-GluN3A infection (infected or not),
F(1,23) = 28.8, p < 0.001; drug-infection interaction, F(1,23) = 9.4, p < 0.01. Two-
way ANOVA. Scale bars represent 50 pA and 5 ms. Error bars represent SEM.
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Figure 4. Pharmacological Activation of
mGluR1 Restores NMDAR Transmission af-
ter Cocaine Exposure
(A) Effect of 5 min application of DHPG on the
amplitude versus time plot and sample traces of
NMDAR-EPSCs recorded at +40 mV (saline:
92.6% ± 5.4% of baseline, n = 6; cocaine:
170.9% ± 14.4% of baseline, n = 14; p < 0.001).
Scale bars represent 50 pA and 100 ms.
(B) Sample traces and bar graph representing
3 mM ifenprodil inhibition on NMDAR-EPSCs with
or without DHPG pre-incubation (percentage of
inhibition in saline: 21.5% ± 2.5%, n = 8; cocaine:
55.0% ± 5.1%, n = 6. p < 0.001. Percentage of
inhibition in saline slices treated with DHPG:
16.3% ± 5.7%, n = 8; cocaine slices treated with
DHPG: 25.8% ± 5.5%, n = 8. p = 1.0). Scale bars
represent 50 pA and 100 ms. Group comparison
statistic for (A) and (B): effect of drug (saline or
cocaine), F(1,23) = 12.6, p < 0.01; effect of DHPG
treatment (DHPG treated or not), F(1,23) = 9.2, p <
0.01; drug-DHPG interaction, F(1,23) = 6.6, p < 0.05.
(Two-way ANOVA.)
(C) Scaled sample traces and decay time for
NMDAR-EPSCs recorded at +40 mV after DHPG
preincubation (Tw in DHPG-saline: 133.0 ±
15.2 ms, n = 6; DHPG-cocaine: 129.1 ± 26.7 ms,
n = 6. p = 0.9).
(D) Sample traces aswell as I-V plots of normalized
and averaged NMDAR-EPSCs of VTA DA neurons
in DHPG-incubated slices (60 mV in DHPG-Sa-
line: 10.4% ± 2.2% of +40 mV, n = 9; DHPG-
cocaine:13.7% ± 3.2% of +40 mV, n = 9. p = 0.3)
(80 mV in DHPG-saline: 7.0% ± 1.2%
of +40 mV, n = 9; DHPG-cocaine: 8.6% ± 1.2%
of +40 mV, n = 9. p = 0.3).
(E) Example traces and normalized calcium tran-
sient in slices from saline mice after DHPG treat-
ment was 87.8% ± 9.7% after PhTx application,
11.8% ± 7.3% after AP5 application (p < 0.01
compared to the PhTx condition), and 5.2% ±
2.6% after NBQX application of baseline (p = 0.3
compared to the AP5 condition) (n = 5).
(F) Example traces and normalized Ca2+ transient
in slices from cocaine mice after DHPG treatment
was 104.7% ± 11.2% after PhTx application,
6.2% ± 3.3% after AP5 application (p = 0.001
compared to the PhTx condition), and 1.4% ±
0.5% after NBQX application of baseline (p = 0.2
compared to the AP5 condition) (n = 5). Scale bars
represent 1% DG/R and 1 s.
Neuron
GluN3A in Cocaine-Evoked PlasticitymGluR1 Activation Restores Basal NMDAR
Transmission
We have previously shown that mGluR1 activation restores
AMPAR-mediated transmission following a single cocaine
injection (Bellone and Lu¨scher, 2006). To test whether mGluR1
activation is also capable of restoring baseline NMDAR-trans-
mission, we applied the mGluR-I agonist DHPG (20 mM) while
recording NMDAR-EPSCs and found a substantial increase in
the current amplitude only in slices from cocaine-treated mice
(Figure 4A). These data are consistent with the removal of low-
conductance GluN3A-containing NMDARs. This potentiation of
NMDAR-EPSCs occurred concomitantly with a decrease in ifen-1030 Neuron 80, 1025–1038, November 20, 2013 ª2013 Elsevier Incprodil inhibition (Figure 4B) andwas associated with faster decay
time kinetics of the evoked NMDAR-EPSCs (Figures 4C, 4D, and
S6A). Furthermore, the difference in the I/V relationship between
cocaine- and saline-treated mice was absent following DHPG
application (Figure 4D). Notably, bath application of DHPG while
recording NMDAR-EPSCs at 60mV in cocaine-treated mice
induced a small depression, probably caused by the removal
of the Mg2+-insensitive, GluN3A-containing NMDARs (Fig-
ure S6B). Confirming the removal of nonconventional NMDARs,
Ca2+ transientsmeasured inMg2+-free solution after DHPG incu-
bation were mediated by NMDARs and did not differ from saline-
treated mice (Figures 4E, 4F, and S6C). Collectively, these data.
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Figure 5. mGluR1-Mediated Potentiation
of NMDAR-EPSCs Depends on Ca2+
Released from IP3Rs through Homer/Shank
Interaction
(A) In the cocaine group, effect of preincubation of
the slices with mGluR1 (LY367385, 25 mM) (open
circles) or mGluR5 antagonist (MPEP, 10 mM)
(filled circles) on the DHPG-induced potentia-
tion of NMDAR-EPSCs recorded at +40 mV.
Top, example traces of the NMDAR-EPSCs.
(LY367385: 94.1% ± 6.8% of baseline, n = 12 p =
0.001; MPEP: 148.4% ± 12.8% of baseline, n = 8.)
(B) Effect of application of DHPG on the amplitude
versus time plot and sample traces of NMDAR-
EPSCs in slices from cocaine group recorded at
40 mV in presence of 10 mM BAPTA in the patch
pipette. (78.4% ± 4.0% of baseline, n = 8.)
(C) On top, the design of a peptide containing nine
amino acids that disrupts Shank-homer interac-
tion. Immunoprecipitation assay demonstrated
the specificity of dnShank3 in disrupting Shank-
homer binding in vivo.
(D) Effect of 5 min application of DHPG on the
amplitude versus time plot and sample traces of
NMDAR-EPSCs in slices from cocaine group re-
corded at +40 mV in presence of dnShank3 (open
circles) or scShank3 (filled circles). (dnShank3:
136.5% ± 7.7% of baseline, n = 6; scShank3
90.4% ± 7.5%, n = 7. p < 0.001.)
(E) In the cocaine group, effect of preincubation of
the slices with CPA (30 mM) (open circles) on the
DHPG-induced potentiation of NMDAR-EPSCs re-
corded at+40mV (80.6%±0.9%of baseline, n = 8).
(F) Effect of 5 min application of DHPG on the
amplitude versus time plot and sample traces of
NMDAR-EPSCs in slices from cocaine group
recorded at +40 mV in presence of 2 mg/ml
Heparin (IP3-receptor blocker) in the pipette
(97.2% ± 3.4% of baseline, n = 8). Scale bars
represent 50 pA and 100 ms. The continuous line
in the graphs represent the same data of Fig-
ure 4A. Scale bars represent 60 pA and 100 ms.
Error bars represent SEM.
Neuron
GluN3A in Cocaine-Evoked Plasticitysuggest that mGluR1 activation is sufficient to re-establish base-
line NMDAR transmission by changing the ratio of GluN2B/
GluN2A/GluN3A subunits.
Signaling Pathway Underlying mGluR1-Induced
Potentiation of NMDARs
Group I mGluRs comprise two receptor subtypes, mGluR1 and
mGluR5, both of which are expressed by DA neurons in the
VTA. As previously demonstrated for AMPAR-mediated trans-
mission (Mameli et al., 2007), we found that the DHPG-induced
potentiation of the NMDAR-EPSCs was mediated by mGluR1
and not mGluR5 since LY367385, but not MPEP, blocked the
NMDAR plasticity (Figure 5A). mGluR1 couples to Gq, triggers
release of Ca2+ from intracellular stores, and can activate variousNeuron 80, 1025–1038, Nosignaling pathways. Since the trafficking
of glutamate receptors relies largely on
Ca2+-dependent mechanisms, we firstinvestigated the role of postsynaptic Ca2+ in the DHPG-induced
potentiation of NMDARs. After loading cells with the Ca2+
chelator BAPTA, DHPG no longer induced a potentiation of the
NMDAR-EPSCs, confirming a necessary role for postsynaptic
Ca2+-dependent signaling (Figure 5B).
Shank/Homer protein interaction plays a major role in
mGluR1-dependent changes of intracellular signaling that
occurs via recruitment of IP3 receptors (IP3Rs) to synapses by
the Shank/Homer complex (Sala et al., 2005; Hayashi et al.,
2009; Verpelli and Sala, 2012). To test whether Shank/Homer
is also required for mGluR1-induced potentiation of NMDARs,
we designed a dominant-negative peptide mimicking the
interaction site of Shank3 with Homer (positions 1307–1316,
LVPPPPEEFAN-sequence; Figure 5C). We first characterizedvember 20, 2013 ª2013 Elsevier Inc. 1031
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Figure 6. mGluR1-Mediated Potentiation of NMDAR-EPSCs Is
Expressed by Fast Protein Synthesis in Response to Activation of
the mTOR Pathway
(A) Effect of application of DHPG on the amplitude versus time plot and sample
traces of NMDAR-EPSCs in slices from cocaine group recorded at 40 mV in
presence of mTOR inhibitor Rapamycin (open circles)(50 nM, 20 min pre-
incubation) (rapamycin: 90.9% ± 10.0% of baseline, n = 6; control: 149.2% ±
3.8%, n = 6. p < 0.001).
(B) Effect of application of DHPG on the amplitude versus time plot and sample
traces of NMDAR-EPSCs in slices from cocaine group recorded at 40 mV in
presence of Anisomycin (open circles) (25 mM, 20 min preincubation) or MEK/
ERK inhibitor U0126 (open circles) (20 mM, 20 min preincubation) (anisomycin:
92.4% ± 4.6% of baseline, n = 8; U0126: 154.9% ± 12.1%, n = 9. p < 0.001).
Scale bars represent 60 pA and 100 ms. Error bars represent SEM.
Neuron
GluN3A in Cocaine-Evoked Plasticitythe dominant-negative peptide (dnShank3) and the scrambled
control peptide (scShank3) in HEK cells that were transfected
with HA-Shank3 and Myc-Homer and the lysate was incubated
with either dnShank3 or scShank3. We performed an immuno-
precipitation with HA-Shank3 followed by a blot with anti-Myc
or anti-HA antibody. We observed that dnShank3 blocked the
interaction between Homer and Shank3 protein in vitro (Fig-
ure 4C). We then loaded DA neurons in acute brain slices with
either dnShank3 or the control scShank3 peptide in the patch
pipette and performed whole-cell recordings of pharmacologi-
cally isolated NMDAR-EPSCs at +40 mV. While neither peptide
affected baseline transmission over a 30 min time period
only the dnShank3 abolished DHPG-induced potentiation of
NMDARs (Figure 5D), demonstrating that the signaling through
the Shank/Homer protein is necessary for mGluR1-dependent
plasticity of NMDARs.
mGluR1 activation triggers release of Ca2+ from internal stores
via activation of the IP3Rs located on the endoplasmic reticulum
(ER, Harnett et al., 2009; Lu¨scher and Huber, 2010). To investi-
gate the contribution of ER calcium stores, we incubated
slices with cyclopiazonic acid (CPA), which selectively blocks
the sarcoplasmic-endoplasmic reticulum Ca2+/ATPase pump
(Kwon and Castillo, 2008). Slices treated with CPA showed no
mGluR1-induced potentiation of theNMDAR-EPSCS (Figure 5E).
We next examined the role of IP3Rs in mediating the release of
intracellular Ca2+. Loading cells with the IP3R blocker heparin
efficiently prevented the DHPG-induced potentiation of the
NMDAR-EPSCs (Figure 5F). Collectively, these data indicate
that the signal transduction between NMDARs and mGluR1s is
dependent on intracellular Ca2+ signaling.
Downstream of Ca2+ signaling, mGluR1 activates both the
extracellular signal-regulated kinase (ERK) and the phosphoino-
sitide 3-kinase-Akt-mammalian target of Rapamycin (mTOR).1032 Neuron 80, 1025–1038, November 20, 2013 ª2013 Elsevier IncWe observed a block of the DHPG-induced potentiation of
NMDARs with rapamycin (Figure 6A), but not with the ERK
pathway inhibitor U0126 (Figure 6B). The involvement of the
mTOR pathway suggests that this form of plasticity is translation
dependent, similarly to what has been reported for mGluR-
LTD of AMPAR transmission (Mameli et al., 2007). Indeed, prein-
cubation of slices with anysomicin blocked mGluR1-induced
plasticity of the NMDAR-EPSCS without affecting baseline
transmission (Figure 6C).
Taken together, our data indicate that mGluR1 activation
reverses cocaine-evokedplasticity ofNMDARsvia aCa2+-depen-
dent signaling transduction pathway, which leads to mTOR acti-
vation and protein-synthesis-dependent regulation of NMDARs.
mGluR1 Plasticity Occurs through NMDAR Trafficking
Next we characterized the expression mechanisms of mGluR1-
dependent potentiation of NMDAR transmission and asked
whether it depended on receptor recruitment and trafficking. In
fact, phosphorylation of the receptor, in particular via PKC acti-
vation, plays amajor role in NMDAR trafficking atmany synapses
(Lau and Zukin, 2007). The PKC pathway is activated by a rise in
intracellular Ca2+ concentration; we therefore tested whether
this kinase would play a role in the mGluR1-induced potentiation
of NMDARs. We incubated slices with a specific PKC inhibitor,
chelerythrine, which blocked the potentiation of NMDA induced
by DHPG application (Figure 7A). In other systems, PKC has
been shown to promote NMDAR trafficking via SNARE-depen-
dent exocytosis (Lau et al., 2010). To test the hypothesis that
mGluR1 activation leads to the delivery of NMDARs at synapses,
we dialyzed tetanus-toxin (TeTx) through the patch pipette,
which allows cleavage of the VAMP2 protein and therefore
blocks exocytosis. While the heat-inactivated (95 degrees for
1 hr) toxin did not affect the mGluR1-induced potentiation of
NMDARs, TeTx blocked the plasticity (Figure 7B). To confirm
this result, we took advantage of a peptide that mimics the C-ter-
minal tail of SNAP-25 protein and interferes with formation of the
SNARE complex (Lau et al., 2010). The SNAP-25 peptide
blocked the mGluR-potentiation of NMDARs when loaded into
the cell, while a scrambled control peptide was without effect
(Figure 7C).
DISCUSSION
Here we elucidate the expression mechanism that underlies the
changes in NMDAR transmission at excitatory synapses on VTA
DA neurons, evoked by a single cocaine injection. We provide
evidence for the exchange of Ca2+-permeable for quasi-Ca2+-
impermeable NMDARs that occurs together with a switch from
CI-AMPARs to CP-AMPARs. We identify GluN3A as the determi-
nant subunit for the Ca2+ permeability of these nonconventional
NMDARs and show that GluN3A-containing NMDARs are
necessary for the expression of cocaine-evoked plasticity in
the VTA. Importantly, together with previous studies (Bellone
and Lu¨scher, 2006; Mameli et al., 2007) we find mGluR1
signaling as the common molecular mechanism responsible for
restoring basal excitatory transmission (AMPAR and NMDAR)
after cocaine exposure (see Figure 8 for NMDARs and Bellone
and Lu¨scher, 2012 for AMPARs). Our data therefore strongly.
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Figure 7. mGluR1-Mediated Potentiation of NMDAR-EPSCs Requires PKC Activation and NMDAR Trafficking via SNARE-SNAP25
Interaction
(A) Effect of application of DHPG on the amplitude versus time plot and sample traces of NMDAR-EPSCs in slices from cocaine group recorded at +40 mV in
presence of PKC blocker Chelerythrine (10 mM, 20 min preincubation) (open circles) (Chelerythrine: 91.8% ± 1.0% of baseline, n = 8). Scale bars represent 60 pA
and 200 ms. The continuous line represents the same data shown in Figure 2B.
(B) Effect of application of DHPG on the amplitude versus time plot and sample traces of NMDAR-EPSCs in slices from cocaine group recorded at 40 mV in
presence of the active (open circles) or inactive (open circles) form of the tetanus toxin in the pipette (100 ng/ml) (tetanus toxin: 100.3% ± 4.1% of baseline, n = 9;
heat-inactivated tetanus toxin (tetanus toxoid): 163.7% ± 4.2%, n = 7. p < 0.001). Scale bars represent 100 pA and 200 ms.
(C) Effect of application of DHPG on the amplitude versus time plot and sample traces of NMDAR-EPSCs in slices from cocaine group recorded at 40 mV in
presence of the short SNAP-25 interfering peptide (SNAP-25 c-term, 300 mM) versus the scramble peptide on mGluR-LTP (SNAP-25 peptide: 96.3% ± 6.4% of
baseline, n = 7; scramble peptide: 168.5% ± 10.0%, n = 10. p < 0.001). Scale bars represent 100 pA and 200 ms. Error bars represent SEM.
Neuron
GluN3A in Cocaine-Evoked Plasticitysupport the idea that mGluR1 signaling controls the GluN3A
content at excitatory synapses onto DA neurons.
NMDARs are heteromeric receptors that can be classified
based on their subunit composition. Three subunit families
have been cloned so far based on sequence homology: GluN1,
GluN2 (A-D), and GluN3 (A-B). While GluN1 is the obligatory sub-
unit, GluN2 and GluN3 subunits determine the functional hetero-
geneity of NMDARs (Monyer et al., 1994; Traynelis et al., 2010).
The existence of specificmodulators for GluN2 subunits, such as
ifenprodil or Zn2+, facilitates the study of the functional proper-
ties of NMDARs (Paoletti, 2011). Pharmacological GluN3A mod-
ulators are not available, but data derived from expression
systems indicate that the presence of GluN3A is responsible
for low channel conductance, low Ca2+ permeability, and low
Mg2+ sensitivity (Das et al., 1998; Perez-Otano et al., 2001;
Tong et al., 2008; Paoletti et al., 2013). Both diheteromeric and
triheteromeric complexes formed by GluN1 with one or two
different GluN2 subunits exist (Al-Hallaq et al., 2007; Gray
et al., 2011). Moreover, transgenic animal models infer the
existence of triheteromeric GluN1/GluN2/GluN3 receptors (Das
et al., 1998; Tong et al., 2008). Recordings of DA neurons of
the VTA after cocaine exposure lead to the observation of
decreased NMDAR-EPSCs (Mameli et al., 2011) along with
very low Ca2+ permeability and low Mg2+ sensitivity, suggesting
the insertion of GluN3A-containing NMDARs at VTA DA synap-
ses. In addition, the change in ifenprodil and Zn2+ sensitivity,
concomitant with an increase in the decay time kinetics, indi-
cates a switch in the relative contribution of GluN2A and GluN2B
following cocaine exposure. Since ifenprodil partially inhibits
NMDAR-EPSCs in saline-treated mice, we cannot exclude the
presence of GluN1/GluN2A/GluN2B triheteromers in baseline
conditions at juvenile synapses. Taken together, our data areNebest explained by a model in which cocaine drives the insertion
of triheteromeric GluN1/GluN2B/GluN3A containing complexes
that replace GluN1/GluN2A diheteromers and GluN1/GluN2A/
GluN2B triheteromers.
The cocaine-driven subunit switch of NMDAR subunitsmimics
observations made during development (Williams et al., 1993;
Sheng et al., 1994; Sanchez et al., 2010). During the first
postnatal week, GluN2B-containing NMDARs are replaced
by GluN2A-containing ones in most glutamatergic synapses,
including excitatory synapses onto VTA DA neurons (Sheng
et al., 1994; Sans et al., 2000; Bellone and Nicoll, 2007). This
postnatal subunit switch is activity dependent, regulates AMPAR
expression, and depends on the activation of group I mGluRs
both in the hippocampus and in the VTA (Bellone et al., 2011;
Matta et al., 2011; Gray et al., 2011). The GluN3A subunit also
has a developmental distribution profile (Wong et al., 2002; Hen-
son et al., 2010). Because of its expression profile, GluN3A may
represent a molecular break for synaptic maturation (Roberts
et al., 2009). In agreement with this idea, GluN3A overexpression
decreases spine density and attenuates LTP induction at CA1
hippocampal synapses (Roberts et al., 2009). Moreover, deletion
of GluN3A accelerates the expression of markers of synaptic
maturation (Henson et al., 2012). Faster synaptic maturation
could result from the loss of GluN1/GluN2B/GluN3A hetero-
trimers and the insertion of GluN2A-containing NMDARs. This
scenario is further supported by the observation that, in the
VTA, neonatal synapses onto DA neurons are characterized by
Ca2+-impermeable NMDARs with high ifenprodil sensitivity and
slow decay time kinetics (Bellone et al., 2011).We therefore favor
a scenario where at neonatal synapses after the birth, NMDAR
synaptic transmission ismediated byGluN3A- andGluN2B-con-
taining subunits that are replaced by GluN2A-containing onesuron 80, 1025–1038, November 20, 2013 ª2013 Elsevier Inc. 1033
Figure 8. Model for Cocaine-Evoked Plasticity of NMDARs and
mGluR1-Induced Reversal
After a single cocaine injection (red arrows), GluN2B/GluN2A-containing
NMDARs are removed from synapses and GluN2B/GluN3A-containing
NMDARs are inserted. The pharmacological activation of mGluR1 (blue
arrows), restores basal synaptic transmission promoting the removal of
nonconventional NMDARs and the insertion of GluN2A-containing NMDARs at
the synapses via Shank3/Homer interaction, Ca2+ release from internal store,
and PKC activation.
Neuron
GluN3A in Cocaine-Evoked Plasticitywithin the third postnatal week. At juvenile and adult synapses, a
single cocaine injection triggers receptor redistribution with the
reappearance of subunits typically present in immature synap-
ses. Such observations lead us to propose that addictive drugs
may reopen a critical period of synapse development (Bellone
and Lu¨scher, 2012).
The role of mGluR1s in orchestrating both AMPARs and
NMDARs is of particular interest. We have previously shown
that mGluR1 drives the postnatal maturation of AMPARs and
NMDARs (Bellone et al., 2011). In the present study we show
that mGluR1 activation restores baseline transmission after
cocaine exposure. mGluR1-mediated restoration of baseline
transmission is not limited to NMDARs in the VTA, but may
also provide an efficient mechanism to reverse cocaine-evoked
plasticity in other brain structures within the mesocorticolimbic
system (Mameli et al., 2007, 2009; McCutcheon et al., 2011;
Loweth et al., 2013). Collectively, these data point to mGluR1
as an important modulator of the synaptic transmission and a
potential target for drug development (Loweth et al., 2013). In
the present study, we have explored the signaling pathway
recruited following mGluR1 stimulation. Interestingly, both
mGluR1-driven AMPAR and NMDAR redistribution share a com-
mon signaling pathway that involves Homer/Shank andmTOR. A
number of other signaling molecules may also be important in
this phenomenon. For example, in culture systems, endocytic
removal of GluN3A is regulated by PACSIN1/syndapin1 (Pe´rez-
Otan˜o et al., 2006). PACSIN contains several potential phos-
phorylation sites for PKC and casein kinase 2 (Plomann et al.,
1998), both of which are implicated in NMDAR subunit regulation
(Sanz-Clemente et al., 2010). SincemGluR1 activation drives the
removal of GluN3A-containing and the insertion of GluN2A-con-1034 Neuron 80, 1025–1038, November 20, 2013 ª2013 Elsevier Inctaining NMDARs via a Ca2+-dependent pathway, it will be of in-
terest to investigate whether mGluR1 activation recruits PACSIN
to promote GluN3A endocytosis.
What might be the functional consequences of changing
NMDAR subunit composition for subsequent activity-dependent
synaptic plasticity? It has previously been proposed that the
GluN2A/2B ratio of NMDARs determines whether given neuronal
activity induces LTP or LTD (Liu et al., 2004). This simple concept
has been challenged (Berberich et al., 2005; Morishita et al.,
2007) and a more likely scenario is that GluN2A and GluN2B
are both involved in potentiation and depression of synaptic
transmission. While GluN2A-containing NMDARs are respon-
sible for Ca2+ influx, GluN2B subunits would play a crucial role
in LTP expression (Foster et al., 2010). GluN3A could also modu-
late synaptic plasticity, suggesting that the expression of this
subunit prevents the induction of synaptic potentiation (Roberts
et al., 2009). While the amplitudes of NMDAR-EPSCs in dissoci-
ated cortical neurons from GluN3A KO mice are increased (Das
et al., 1998), the ratio of the NMDAR- to AMPAR-EPSCs is higher
in GluN3A KO mice than in WT mice (Tong et al., 2008). These
data may reflect a larger NMDAR component, suggesting that
GluN3A can affect the synaptic transmission in a naive system
(Tong et al., 2008).
With respect to DA neurons of the VTA, cocaine exposure
drives the redistribution of both NMDARs and AMPARs (Schil-
stro¨m et al., 2006; Bellone and Lu¨scher, 2006; Argilli et al.,
2008; Conrad et al., 2008; Mameli et al., 2011), which profoundly
affects excitatory transmission. For example, pairing presynap-
tic stimulation of glutamatergic afferents with postsynaptic burst
firing of DA neurons leads to an LTP of the NMDAR-EPSCS
(Harnett et al., 2009), which is enhanced after amphetamine
(Ahn et al., 2010) or ethanol exposure (Bernier et al., 2011). In
baseline conditions, GluN2A-containing NMDARs are Ca2+
permeable. After cocaine exposure, these NMDAR subtypes
are replaced byGluN2B/GluN3A-containing NMDARs, in parallel
with the insertion of GluA2-lacking CP-AMPARs (Bellone and
Lu¨scher, 2006). The source of synaptic Ca2+ switches from
NMDAR to AMPAR dependent. As a consequence, themost effi-
cient protocol to promote synaptic Ca2+ entry shifts from depo-
larization through canonical NMDARs to hyperpolarization of the
Ca2+-permeable AMPARs. In line with this prediction, the typical
NMDAR-dependent LTP of AMPARs is also absent after cocaine
(Argilli et al., 2008; Luu and Malenka, 2008; Mameli et al., 2011),
probably due to a change in NMDARs that are no longer able to
induce plasticity.
The observation that targeted deletion of GluN3A abolished
the cocaine-driven NMDA subunit redistribution indicates that
GluN3A is necessary for the expression of cocaine-evoked plas-
ticity of both AMPAR- and NMDAR-mediated transmission. A
critical step will be to understand the role for GluN3 in behavioral
changes triggered by cocaine experience. Previous studies have
explored the link between cocaine-evoked plasticity and addic-
tion-relevant behaviors (Engblom et al., 2008; Mameli et al.,
2009). Notably, deletion of the GluN1 subunit specifically in
dopamine neurons, using a NR1 floxed x DAT cre mouse line,
was found to impair reinstatement of cocaine seeking in both
conditioned place preference and drug self-administration para-
digms (Engblom et al., 2008; Zweifel et al., 2008; Mameli et al.,.
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statement was due in part to a loss of GluN3-containing NMDAR
subunits in VTA neurons. Although we saw no differences in both
behavioral sensitization to cocaine and CPP using an ShRNA
approach, we might predict that GluN3A plays an important
role in the ability of cocaine-associated stimuli to trigger relapse
to drug seeking.
The tight coupling of NMDAR and AMPAR redistribution also
raises the possibility that at other synapses, where GluA2-lack-
ing AMPARs have been observed, the NMDA transmission
may be affected. For example, CP-AMPARs are present at excit-
atory synapses onto interneurons in the cortex and hippocam-
pus (Liu and Zukin, 2007). In these cells, an anti-Hebbian form
of LTP that is induced by Ca2+ entering the cells through
AMPARs can be observed (Lamsa et al., 2007). Whether Ca2+-
impermeable NMDAR are also present at these synapses has
not been investigated. As described above, both CP-AMPARs
and GluN3A-containing NMDARs are present at many synapses
during the early postnatal development (Ho et al., 2007; Henson
et al., 2010; Bellone et al., 2011) and may be permissive for cir-
cuit formation in the developing brain and for activity-dependent
changes in the mature brain.
Regardless of the identity of the molecular linker, the subunit
switch for NMDARs and AMPARs represents a form of meta-
plasticity. Rather than encoding specific events, cocaine sets
the rules for subsequent activity-dependent synaptic plasticity
(Mameli et al., 2011). After cocaine, NMDAR activation no longer
induces LTP (because of the insignificant Ca2+ permeability),
which, however, can be rescued when hyperpolarizing the
cell during the induction protocol (thus favoring Ca2+ entry via
GluA2-lacking inwardly rectifiying AMPARs). Through this
switch, cocaine-evoked synaptic plasticity of excitatory trans-
mission in the VTA plays a permissive role for circuit adaptations
in target regions (Mameli et al., 2009). Boosting mGluR1s, for
example with positive allosteric modulators to remove GluN3-
containing NMDARs, may ultimately restore normal synaptic
transmission, prevent adaptations in downstream circuits, and
stop the development of addiction.EXPERIMENTAL PROCEDURES
Animals
C57/BL6 mice (male and female) and NR3A heterozygotes and knockouts
were injected with cocaine (15 mg/kg i.p.) or the same volume of saline as con-
trols. The dose of cocaine that we used did not induce seizures or increase
mortality. The study was conducted in accordancewith the Institutional Animal
Care and Use Committee of the University of Geneva and with permission of
the cantonal authorities (Permit No. 1007/3592/2).
Electrophysiology
The majority of electrophysiology recordings were undertaken in young mice
(P14–40) to facilitate identification of VTA cells. However, note that maturation
of excitatory transmission in the VTA of mice is complete at P14 (Bellone et al.,
2011) and we have also reported cocaine-evoked plasticity of VTA DA neuron
excitatory synapses in adult mice (aged 7 months, Mameli et al., 2009). After
animals were sacrificed, 250-mm-thick horizontal midbrain slices containing
the VTA were prepared and whole-cell voltage-clamp recordings were made
as previously shown (Bellone and Lu¨scher, 2006). The access resistance
was monitored by a hyperpolarizing step of 14 mV with each sweep, every
10 s. The cells were recorded at the access resistance from 10–25 MU, andNedata were excluded when the resistance changed > 20%. Synaptic currents
were evoked by stimuli (0.05–0.1 ms) at 0.1 Hz through a stimulating electrode
placed rostral to the VTA. The experiments were carried out in the presence of
GABAA receptor antagonist picrotoxin (100 mM); the AMPAR EPSCs were
pharmacologically isolated by application of the NMDARs antagonist D, L-
APV (100 mM), whereas the NMDA EPSCs were pharmacologically isolated
by the application of the AMPARs antagonist NBQX (10 mM). Representative
example traces are shown as the average of 20 consecutive EPSCs typically
obtained at each potential or, in the case of plasticity protocols, during the
last 5 min of the baseline and at least 30 min after the induction of plasticity.
The decay time tw of NMDA EPSC was calculated as described previously
(Bellone and Nicoll, 2007). The rectification index of AMPARs is the ratio of
the chord conductance calculated at negative potential divided by the chord
conductance at positive potentials. I-V curves of pharmacologically isolated
NMDARs were generated holding the cells at different membrane potential
for 5 min each and normalizing EPSCs at 40 mV. Tricine (N-tris(hydroxy-
methyl)methylglycine, 10 mM) was used to buffer zinc following the relation-
ship [Zn]free = [Zn]added/200 (Paoletti et al., 1997).
All drugs were purchased from Tocris, except Tetanus Toxin that was pur-
chased from Sigma Aldrich. The peptides were synthetized by China Peptides
with 95% purity and TFA was transferred to phosphate for neutral pH
(Shanghai, China).
RNA Interference
A 59 bp fragment encoding a 19-bp-long small hairpin RNA (shRNA) specific
for rat and mouse GluN3A (sh-GluN3A target sequence: CTACAGCTGAGTT
TAGAAA) was used. Selectivity was tested in cultured cortical neurons in-
fected with viral vectors expressing the sh-GluN3A by immunoblot quantifica-
tion of endogenous levels of GluN3A and other neuronal proteins. Cultured
neurons were collected in lysis buffer containing Tris 50 mM, EDTA 2 mM,
and 1% TX-100 and supplemented with protease inhibitors (Roche Complete).
Proteins in the lysate were separated by SDS-PAGE and transferred onto
PVDF membranes, and membranes were probed with the following primary
antibodies: anti-GluN3A (Millipore, 1:1000), anti-GluN2B (NeuroMab, clone
N59/20, 1:100), anti-GluA1 (Chemicon, 1:1000), anti-GluN2A (Millipore, clone
AW12, 1:1000), anti-PSD-95 (Millipore, 1:10000), and anti-tubulin (Sigma,
1:10000).
Stereotaxic Injection
Injections of purified AAV5-shRNA-GFP were performed in 2-week-old mice.
The animals were anesthetized and maintained with isoflurane (Baxter AG,
Vienna, Austria) at 5% and 1% (in oxygen), respectively. The animals were
then placed on the stereotaxic frame (Angle One; Leica, Germany) and unilat-
eral craniotomy were made over the VTA at following stereotaxic coordinates
(ML 0.5 to 0.6, AP 3, DV 4.2 from Bregma). The virus was injected with grad-
uated pipettes (Drummond Scientific Company, Broomall, PA) (tip diameter of
10–15 mm) at the rate of 100 nl/min for a total volume of 500 nl. In all exper-
iments the virus was allowed a 15–20 days to incubate before any other pro-
cedures were carried out.
Behavioral Experiments
Wild-type C57BL6 mice aged 4–5 weeks at study starts were bilaterally in-
jected with a virus expressing shGluN3A or GFP (n = 8) into the VTA. Three
weeks after the infection, mice were exposed to a nonbiased three-chamber
CPP procedure comprising a single 20 min preconditioning test (pre) followed
by four once-daily cocaine (10 mg/kg i.p.) and four once-daily saline 30 min
conditioning sessions (alternating order) and finally a single 20 min postcondi-
tioning test (post). Locomotor activity was video tracked and analyzed with
ANY-maze behavioral software (Stoelting, Illinois, USA).
Immunohistochemistry
The animals were sacrificed and transcardially perfused with 0.01 M PBS
followed by 4% paraformaldehyde in phosphate buffer. The brain was then
removed and left for overnight postfixation at 4C. Horizontal VTA slices
were cut at 50 mm and washed three times in PBS before incubation in the
blocking solution containing 0.3% triton, 5% BSA, and 2% goat serum.
Then the slices were incubated with rabbit anti-TH (Millipore, 1:500) at 4Curon 80, 1025–1038, November 20, 2013 ª2013 Elsevier Inc. 1035
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with secondary antibody goat anti-rabbit IgG-Alexa 568 (Invitrogen, 1:200).
Finally, the slices were washed three times in PBS before being mounted
onto the slides with Dako DAPI-mounting medium.
Calcium Imaging with Two-Photon Microscopy
Dendritic fluorescence was measured with a two-photon laser-scanning
microscope based on the Olympus FV-300 system (side-mounted to a
BX50WI microscope with a 403, 0.8 NA water-immersion objective) and a
Mai-Tai laser (Spectra Physics) operating at 830 nm. Green and red fluores-
cence signals were acquired simultaneously in line-scan mode where the
line scan was oriented along the dendrite and quantified as increases in green
fluorescence normalized to red fluorescence (DG/R). Synaptic stimulation was
obtained with a glass pipette located proximally to the dendrite. Neurons were
voltage clamped at60mV to detect amixture of AMPAR- andNMDAR-medi-
ated responses in Mg2+-free aCSF containing 100 mM picrotoxin, 50 mM
mibefradil (T-type voltage-gated calcium channel [VGCC] blocker), and
100 mMnimodipine (L-type VGCCblocker). The intracellular solution contained
130 mM cesium-methanesulphonate, 10 mM HEPES, 10 mM sodium phos-
phocreatine, 4 mM MgCl2, 4 mM Na-ATP, 0.4 mM Na-GTP, 0.1 mM Oregon
green BAPTA1, and 0.02 mM AlexaFluo Red. After obtaining the whole-
cell configuration, 15–20 min were allowed for intracellular diffusion of
fluorophores.
Biochemical Peptide Characterization
HEK cells were cotransfected with HA-Shank3 and Myc-Homer1b cDNAs
(Romorini et al., 2004; Roussignol et al., 2005) in the mammalian expression
vector pGW1-CMV using Lipofectamine 2000 (Invitrogen). Two days after
transfection the cells were extracted in buffer A containing 200 mM NaCl,
10 mM EDTA, 10 mM Na2HPO4, 0.5% NP-40, 0.1% SDS, and protein inhibitor
cocktails. For the coimmunoprecipitation, samples (100 mg proteins) were
incubated overnight at 4C with antibodies (rabbit anti-HA antibodies 1:200,
Roche Applied Science) in presence of 100 mM dominant-negative peptide
(dnShank3) LVPPPEFAN or scrambled peptide (scShank3) PANFLPVPE. Pro-
tein A agarose beads (Santa Cruz Biotechnology) washed in the same buffer
were added, and incubation continued for 2 hr. The beads were collected by
centrifugation and washed five times with buffer A. Samples were resus-
pended in sample buffer for SDS-PAGE, and the mixture was boiled for
5 min. Beads were pelleted by centrifugation, and supernatants were applied
to 7.5% or 10% SDS-PAGE. The following antibodies were used: goat anti-
iL1RAPL1 (R&D Systems) at dilution 1:1000, mouse anti-HA (Santa Cruz
Biotechnology), rabbit anti-Myc-tag (Santa Cruz Biotechnology), and mouse
anti-HA-tag (Roche Applied Science).
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